Siren LLC’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$133M Hold
465,000
2.68% 9
2026
Q1
$138M Sell
465,000
-35,000
-7% -$11.3M 3.83% 5
2025
Q4
$152M Buy
500,000
+7,010
+1% +$2.29M 4.53% 3
2025
Q3
$168M Sell
492,990
-17,000
-3% -$5.16M 6.57% 3
2025
Q2
$123M Buy
509,990
+11,301
+2% +$2.77M 6.39% 3
2025
Q1
$136M Sell
498,689
-155,032
-24% -$36.2M 7.66% 2
2024
Q4
$121M Buy
653,721
+90,407
+16% +$18.5M 5.33% 2
2024
Q3
$126M Buy
+563,314
New +$101M 6.32% 2

Other funds holding ONC

Siren LLC's ONC Position: Q2 2026 in Review

Siren LLC held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 465,000 shares worth $133M. The position accounts for 2.68% of the portfolio, ranked #9.

Siren LLC first reported a position in ONC in Q3 2024 and has held it in 8 quarters since. The position peaked at $168M in Q3 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Siren LLC held 465,000 shares of BeOne Medicines Ltd worth $133M as of Q2 2026.
  • Siren LLC left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up 2.68% of Siren LLC's portfolio in Q2 2026, its #9 holding.
  • Siren LLC first reported a position in BeOne Medicines Ltd in Q3 2024 and has held it in 8 quarters since.
  • Siren LLC's BeOne Medicines Ltd position peaked at $168M in Q3 2025.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Siren LLC's 13F filing for Q2 2026, filed 13 Aug 2026.